A Day Up For ImmunityBio, Inc.
Wed, Feb 18, 2026 at 07:32 PM
ImmunityBio, Inc. (IBRX:NASDAQ) soared at $8.54, representing a gain of 41.9%. On Wed, Feb 18, 2026, IBRX:NASDAQ hit a New 2-Week High of $8.54. The stock appeared on our News Catalysts scanner on Wed, Feb 18, 2026 at 04:37 PM in the 'MISCELLANEOUS' category. From Wed, Feb 04, 2026, the stock recorded 55.56% Up Days and 40.00% Green Days
About ImmunityBio, Inc. (IBRX:NASDAQ)
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
Top 10 Gainers:
- Rackspace Technology, Inc. (RXT:NASDAQ), 226.97%
- Sensei Biotherapeutics, Inc. (SNSE:NASDAQ), 187.51%
- Cardio Diagnostics Holdings, Inc. (CDIO:NASDAQ), 78.99%
- Moolec Science SA (MLEC:NASDAQ), 49.9%
- RenX Enterprises Corp Com (New) (RENX:NASDAQ), 44.88%
- ImmunityBio, Inc. (IBRX:NASDAQ), 41.86%
- Neo-Concept International Group Holdings Limited (NCI:NASDAQ), 38.47%
- TMD Energy Limited (TMDE:NYSEMKT), 38.18%
- Auddia Inc. (AUUD:NASDAQ), 36.56%
- SCWorx Corp. (WORX:NASDAQ), 35.7%